Related Experiment Video
Updated: Sep 19, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Molecular dynamics-driven drug discovery
Dengjie Yan1, Yue Ma1, Xiang Chen1
1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China. qwang@scu.edu.cn.
Molecular dynamics (MD) simulations accelerate early drug discovery by aiding target modeling, binding prediction, virtual screening, and lead optimization. Future improvements focus on force fields, sampling, and AI integration for enhanced accuracy and speed.
Area of Science:
- Computational Chemistry
- Pharmacology
- Biophysics
Background:
- Molecular dynamics (MD) simulation is a powerful computational technique widely utilized across scientific disciplines.
- Its application in drug discovery is particularly significant, especially during the early stages of compound identification.
Purpose of the Study:
- To review recent applications of MD simulation in key early drug discovery areas.
- To discuss current limitations and future directions for MD simulation in pharmaceutical research.
Main Methods:
- Focus on four primary applications: target modeling, binding pose prediction, virtual screening, and lead optimization.
- Analysis of current challenges and potential solutions for MD simulations in drug discovery.
Main Results:
- MD simulations offer valuable insights in target identification and validation.
- Accurate prediction of drug-target interactions is crucial for virtual screening and lead optimization.
- Recent advancements have enhanced the utility of MD simulations in accelerating the drug discovery pipeline.
Conclusions:
- MD simulation is indispensable for modern drug discovery, particularly in the early compound discovery phase.
- Addressing challenges in force fields, sampling techniques, and integrating artificial intelligence will further improve MD simulation's accuracy and efficiency.
- Continued development promises to significantly expedite the identification and optimization of novel drug candidates.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

